Recent findings have shown that, in addition to the genomic action of steroids, through intracellular receptors, short-time effects could be mediated through binding to membrane sites. In the present study of prostate cancer LNCaP cells, we report that dihydrotestosterone and the non-internalizable analog testosterone-BSA increase rapidly the release of prostate-specific antigen (PSA) in the culture medium. Membrane testosterone binding sites were identified through ligand binding on membrane preparations, flow cytometry, and confocal laser microscopy of the non-internalizable fluorescent analog testosterone-BSA-FITC, on whole cells. Binding on these sites is time-and concentration-dependent and specific for testosterone, presenting a K D of 10.9 nM and a number of 144 sites/mg protein (~13000 sites/cell). Membrane sites differ immunologically for intracellular androgen receptors. The secretion of PSA after membrane testosterone receptor stimulation was inhibited after pretreatment with the actin cytoskeleton disrupting agent cytochalasin B. In addition, membrane testosterone binding modifies the intracellular dynamic equilibrium of monomeric to filamentous actin and remodels profoundly the actin cytoskeleton organization. These results are discussed in the context of a possible involvement of these sites in cancer chemotherapy.
was collected and centrifuged for 10 min at 1500 rpm. We measured total PSA in the supernatant in an AxSim apparatus (Abbott, Chicago IL) by using the corresponding kit from the same source, which was normalized according to the total number of cells.
We assayed cell numbers by using the tetrazolium salt assay (18) . Cells were incubated for 3 h at 37 û C with the tetrazolium salt (3-(4,5 dimethylthiazol-2-yl)-2,5 diphenyl tetrazolium bromide; Sigma). Living cells reduced the dye to purple formazan, seen as dark blue crystals. At the end of the incubation period, they were dissolved with propanol-1 and the absorbance was measure at 575 nm, within 1 h.
Detection of androgen receptors

Detection of classical androgen receptors
Immunocytochemistry: LNcap cell smears on SuperFrost/Plus slides (Kindler O GmbH, Freiburg, Germany) were fixed in cold acetone for 5 min and were then air-dried. Before immunostaining, the slides were pretreated with citrate buffer with pH adjusted at 10, in a microwave oven, at 500 Watts for 3 min. Anti-human androgen receptor monoclonal andibody (clone AR441, code # M3562; DAKO, Carpinteria, CA) was used at a 1/25 dilution for 60 min. The immunostaining method applied was an indirect alkaline phosphatase method (alkaline phosphatase-conjugated rabbit anti-mouse immunoglobulins, 1/50 dilution, DAKO, Glostrup Denmark) with Fast Red TR (DAKO, Fast Red substrate system). Specimens were studied in a Nikon Microphot-FXA microscope, mounted with a Nikon DX-DB2 photographic camera.
Independently, for the possible detection of membrane testosterone receptors, we fixed LNCaP cells with cold acetone, incubated with the same anti-androgen receptor antibody for 5 min. Thereafter, the cell suspension was washed with phosphate buffered saline (PBS) and mounted on SuperFrost/Plus slides, and the same indirect alkaline phosphatase method, as described above, was applied, without pretreatment with citrate buffer.
Ligand binding: Cells (1-2 × 10 6 ) were seeded in 6-well culture dishes and were cultured for 2 days in a medium containing FBS and for an additional day in culture medium without FBS. Afterwards, medium was aspirated and cells were washed twice with PBS. Binding was performed on whole cells in PBS, in a total volume of 0.5 ml. Eight different concentrations of radio-labeled testosterone ([ 3 H]testosterone, specific activity 95 Ci/mmole, AmershamPharmacia, Buckinghabshire, UK) were used for saturation binding, varying from 50 to 0.1 nM. A thousand-fold excess of non-labeled testosterone or DHT was introduced for the estimation of non-specific binding. After a 2-h incubation at room temperature, the medium was aspirated, cells were washed twice with 1 ml ice-cold PBS, removed from plates with 1 ml 1 N NaOH, and mixed with 10 ml scintillation cocktail (SigmaFluor; Sigma). The bound radioactivity was counted in a scintillation counter (Tricarb, Series 4000, Perkin Elmer, Foster City, CA), with 60% efficiency for Tritium. Binding was repeated at least three times (in duplicate). The results were analyzed by the Origin (MicroCal Co.) V 5 package, with equations described by Munson and Rodbard (19) . Cell number was assayed by the tetrazolium method as described above.
Detection of membrane androgen receptors
Binding assays
Membrane preparation: Cells, cultured in 150 cm 2 flasks without serum, were washed twice with PBS, removed by scraping, and centrifuged at 1500 rpm. Pelleted cells were homogenized by sonication in 50 mM Tris-HCl buffer, pH 7.4, containing freshly added protease inhibitors (10 µg/ml PMSF and 1µg/ml aprotinin). Unbroken cells were removed by centrifugation at 2500 g for 15 min. Membranes were obtained by centrifugation at 45,000 g for 1 h and were washed once by the same buffer. Protein concentration was measured by the method of Bradford (20) .
Binding conditions: Saturation binding experiments were performed in a final volume of 0.1 ml, containing cell membranes at a final protein concentration of 2 mg/ml and at least six different concentrations of [ 3 H]testosterone (ranging from 2 to 50 nM) without (total binding) or with (non-specific binding) a 1000-fold molar excess of unlabelled androgen (DHT). For displacement binding experiments, cell membrane preparations at a final concentration of 2 mg/ml were incubated with 5 nM of [ 3 H]testosterone in the absence or in the presence of different concentrations of unlabeled steroid (DHT, estradiol, progesterone), ranging from 10 -12 to 10 -6 M. Non-specific binding was estimated in the presence of 5 µΜ DHT. In both types of binding experiments, after an overnight incubation at 4 û C, bound radioactivity was separated by filtration under reduced pressure through GF/B filters previously soaked in 0.5% polyethylenimine (PEI) in water and rinsed three times with ice-cold Tris-HCl buffer. Filters were mixed with 4 ml scintillation cocktail and the bound radioactivity was counted in a scintillation counter (Tricarb, Series 4000, Packard) with 60% efficiency for Tritium.
Flow cytometry
LNCaP cells, cultured in serum-free medium for 24 h, were detached from the culture flask by scraping and were suspended in PBS at a density of 10 6 cells/ml. They were incubated at room temperature with 10 -7 M testosterone-BSA-FITC conjugate for different periods (1 min to 1 h). A 1000-fold BSA-FITC was used to determine non-specific binding. Cells were analyzed by flow cytometry by using a Coulter Epics XL-MCL apparatus (Beckman-Coulter Inc., Fullerton CA) in a sample size of 10,000 cells gated on the basis of forward and side scatter. Testosterone 3-(O-carboxymethyl)oxime-BSA-FITC and BSA-FITC were obtained from Sigma.
Confocal laser microscopy
LNCaP cells were allowed to grow on poly-L-lysine-coated glass coverslips for at least 48 h before culture medium was replaced with serum-free medium. After a 24-h period, cells were washed twice with PBS and incubated with testosterone-BSA-FITC for 30 min in the presence or in the absence of DHT. We used BSA-FITC as a negative control. Cells were then washed twice with PBS and fixed with 2% PFA in PBS for 30 min. Coverslips were mounted on to slides by using a 1:1 (v/v) mixture of glycerol and Vestashield (Vector, Burlingame, CA). We analyzed specimens by using a confocal laser scanning microscope (CLSM) (Leica TCS-NT).
Determination of the monomeric and polymerized actin
For measurements of the monomeric (Triton soluble) and polymerized (Triton insoluble) actin, LNCaP cells were incubated for 10 min with or without DHT or testosterone-BSA (10 -7 M). Then, 500 µl of Triton-extraction buffer (0.3% TritonX-100; 5 mM Tris, pH 7.4; 2 mM EGTA; 300 mM sucrose; 2 µM phalloidin; 1 mM PMSF; 10 µg/ml leupeptin; 20 µg/ml aprotinin; 1 mM sodium orthovanadate; and 50 mM NaF) were added, and the mixture was incubated for 5 min on ice. After removing the buffer, soluble proteins were precipitated with equal volumes of 6% PCA. The Triton-insoluble fraction remaining on the plate was precipitated with 1 ml of 3% PCA. Equal volumes of each fraction were subjected to sodium dodecyl sulfate-polyacrylamide gel electrophoresis. The resulting protein-bands were transferred onto nitrocellulose membrane, and the membrane was blocked with 5% nonfat dry milk in TBS-T (20 mM Tris, pH 7.6; 137 mM NaCl; 0.05% Tween-20) for 1 h at room temperature. Antibody solutions (in TBS-T) were added for 1 h at room temperature [monoclonal mouse anti-actin first antibody (AmershamPharmacia, Buckinghamshire, UK) and second horseradish peroxidase-coupled antibody (Chemicon, Temecula, CA)]. Blots were developed by using the ECL system (AmershamPharmacia, Buckinghamshire, UK), and the band intensities were quantitated by PC-based image analysis (Image Analysis Inc., Ontario, Canada) (21) .
Confocal laser scanning microscopy of the cytoskeleton
The procedure of cell fixation and direct fluorescence staining of microfilaments by rhodaminephalloidin included incubation of cells with 3.7% formaldehyde, which was followed by a short incubation with acetone at -20ûC. The cells were then incubated for 40 min at room temperature with rhodamine-phalloidin to stain the filamentous actin. Slides were mounted by using the Slow Fade Antifade kit (Molecular Probes, Inc). The coverslips were analyzed by using a confocal laser scanning module (Leica Lasertechnik, Heidelberg, Germany), attached to an inverted microscope (Zeiss IM35, Zeiss, Oberkochen, Germany), equipped with an argon-krypton ion laser (22) (23) (24) .
RESULTS
Testosterone induces PSA secretion by LNCaP cells
PSA secretion is an androgen-related phenomenon (25) . This was also found in the LNCaP hormone-sensitive cell line used in this study. As shown in Figure 1A , both testosterone and its biologically active metabolite dihydrotestosterone (DHT) increased, in a dose-dependent manner, the secretion of PSA, after a 24-h incubation. This effect involves intracellular androgen receptors and modulation of androgen-dependent PSA gene, through the induction of an androgen responsive element (25) .
In the present work, we have applied testosterone for short incubation times (1 min to 1 h) and measured its effect on PSA secretion. Our results are presented in Figure 1B . As shown, DHT increased significantly, by ∼20%, PSA secretion after 10 min. In addition, the same effect was equally found when testosterone was replaced by BSA-testosterone conjugate, which cannot penetrate the cell, indicating a membrane-mediated effect of testosterone. The same membrane effect was found after 30 and 60 min of incubation with testosterone and BSA-testosterone.
However, flutamide, a non-steroidal antiandrogen, induced also an increase of PSA secretion after 10 min incubation (Fig. 1C) . The effect of the combined addition of testosterone-BSA and flutamide was additive, indicating that the action of the antiandrogen might be exerted at the same membrane site as that of testosterone-BSA conjugate. This site might also differ from the classical androgen receptor, on which anti-androgens exert an inhibitory action of androgenmediated effects.
Detection of classical androgen receptors
The above result indicates that testosterone might bind to membrane sites on LNCaP cells. Reports by other investigators in different cell systems, using other steroids, indicate that membrane sites differ from intracellular classical steroid receptors (3) (4) (5) (6) (7) . By using an antiandrogen-receptor primary antibody, we could identify, as expected, cytosolic and nucleartranslocated androgen receptors in LNCaP cells (Fig. 2) . In contrast, no membrane staining was obtained when cells were incubated with the same antibody, in the absence or in the presence of testosterone (not shown). This result indicates that testosterone membrane sites might be (at least immunologically) different from intracellular classical androgen receptors.
Membrane binding of testosterone in LNCaP cells
The above results of short-term effect of testosterone and BSA-testosterone on PSA secretion indicate the possible presence of specific membrane binding sites of testosterone, as it was reported previously for estrogen, progesterone, glucocorticoids, and testosterone in androgeninsensitive cells (3-7, 9-11). To investigate further the presence of such binding sites in LNCaP cells, we used a testosterone-BSA-FITC conjugate, which cannot translocate in the cell. FITCrelated fluorescence was followed by flow cytometry and was identified by confocal laser microscopy. As shown in Figure 3 , after 1 min of incubation, 50% of the cells were labeled specifically by the testosterone-BSA-FITC conjugate. With progressing time, an increase in specific fluorescence intensity was observed, which reached a maximum after a 30-min incubation period. It was reduced when LNCaP cells where incubated with testosterone-BSA-FITC in the presence of 1000-fold excess of DHT (data not shown). Confocal laser microscopy ( Fig. 4) revealed a specific membrane staining after incubation of cells with the testosterone-BSA-FITC conjugate. The specific fluorescence intensity was increased from 1 to 30 min, while no evidence of an intracellular translocation of the conjugate was found.
Detection of plasma membrane binding sites
To further identify specific membrane testosterone binding sites, we performed saturation binding of radiolabelled testosterone, in membrane preparations of LNCaP cells, cultured in the absence of serum, in order to eliminate the presence of sex hormone binding globulins. As shown in Figure 5A , [ 3 H]testosterone, ranging from 1 to 50 nM, induces a specific saturable binding. Scatchard analysis of the results (Fig. 5A, insert) Figure 5B , DHT produced a displacement of radiolabeled testosterone. In contrast, estradiol and progesterone displaced radiolabelled testosterone with a significant lower affinity (10 4 -and 10 2 -fold, respectively), confirming the androgen selectivity of the identified membrane-binding site.
Cytochalasin B affects DHT induced PSA secretion
As shown in Figure 1 , membrane testosterone binding sites activation resulted in an increased secretion of PSA. PSA, a serine-protease, is stored in intracellular secretion vesicles (3, 16, 25) . To verify whether cytoskeleton modifications were involved in this phenomenon, we analyzed the effects of cytochalasin B, an actin cytoskeleton disrupting agent, on testosterone-induced PSA secretion. As shown in Figure 6 , the secretion of PSA decreased significantly in control cells, which had been incubated with 100 µg/ml cytohalasin B, whereas incubation of cells with 10 -7 M DHT for 30 min led to a significant increase of PSA release. Preincubation of cells with cytochalasin B, before the application of DHT, resulted in a complete reversion of DHT effects on PSA release. This effect was comparable with the action of cytochalasin B on control cells, which suggests the involvement of actin cytoskeleton in the effect of membrane testosterone action. Similar results were obtained when DHT was replaced by testosterone-BSA conjugate.
Short incubation with DHT modifies the dynamic equilibrium between monomeric (G) and filamentous (F) actin, and redistributes the actin cytoskleleton
To further analyze the involvement of membrane testosterone binding sites on the actin cytoskeleton, we have measured possible modifications of the actin polymerization dynamics in LNCaP cells after short testosterone incubation. This was achieved either by quantitative immunoblot analysis of the Triton X-100 soluble (TS) and insoluble (TI) actin cytoskeleton fractions of cells exposed to androgens for 10 min, or by the direct identification of the actin cytoskeleton redistribution revealed by rhodamine-phalloidin staining and confocal laser microscopy. Figure 7 , the TS/TI actin ratio decreased significantly by 36% and 47% 10 min after DHT or testosterone-BSA application, respectively, indicating an increase in the proportion of filamentous actin. These quantitative data were confirmed by confocal laser microscopic analysis of the actin cytoskeleton in LNCaP cells incubated with DHT or testosterone-BSA. A submembrane redistribution of the actin polymers became evident, as shown in Figure 8 .
Both techniques have been used widely recently to analyze the rapid intercellular modifications of the actin cytoskeleton dynamics (21, 26). As shown in
DISCUSSION
Prostate cancer is the second most common neoplasia in men. It is a hormone-regulated cancer, and its treatment involves antiandrogen adjuvant therapy (27) . Steroid hormones, which include androgen, estrogen, progesterone, and gluco-and mineralocorticoids, are small molecules that move freely through the cell membrane and exert their actions through binding to intracellular receptors. The complex androgen-androgen receptor dimerizes, translocates to the nucleus, binds to specific responsive elements of DNA, and affects the transcription of androgen-responsive genes. This pathway is the classical model of action for all steroids and is exerted after relative long times of steroid application (>60 min), because it involves mRNA and protein synthesis (genomic action) (28, 29).
In recent years, however, it was reported that, in addition to this genomic effect, steroid hormones could also exert short time effects that are not mediated via the classical receptors (7, 8, (30) (31) (32) (33) (34) (35) (36) . Increasing evidence indicates that those short-time effects might be mediated through membrane steroid binding sites, explaining the very rapid effect of steroids in non-classical steroid receptor-bearing cells and cell lines. In all reported cases, this membrane steroid hormone-binding site induces intracellular free calcium flux (7, 9-13, 30, 33-36) . In addition to steroid receptors, membrane sites for steroid binding proteins have been detected (37; see 38 for a review), on which steroid hormones are natural competitors of SHBG binding (39) (40) (41) (42) .
The first evidence of a non-genomic membrane testosterone action was reported in 1984. Diez et al (43) have shown that hepatic glucogen phosphorylase activity was enhanced in chicken liver by testosterone, through a protein synthesis-insensitive mechanism and a Ca ++ -dependent mechanism. Membrane testosterone binding sites have been identified in chicken osteoblasts, Sertoli cells (13, 14) , and rat T cells (both CD4 and CD8 positive), inducing intracellular Ca ++ fluxes (10, 11) and macrophages (11), rat epididymis (44), and rat ventral prostate. In this later case, activation of a 180-kDa membrane component occurred at a testosterone range from 0.14 to 14.0 nM (45) . In addition, a membrane effect of testosterone on aortic vasorelaxation was found in rat aorta, through a K + -channel mediated action (46) . Moreover, testosterone was found to regulate chlorine secretion from rat efferent duct cells, through a forscolin-related mechanism (47) .
The results of the present study show, for the first time, a functional androgen-binding element on membranes of the human prostate cancer cell line LNCaP. This component seems to be different from classical intracellular androgen receptors, because an antibody against classical androgen receptors does not recognize it, and antiandrogen show the same action as testosterone. It presents all characteristics of a true binding site as saturable (Fig. 5A ) and selective for androgen (Fig. 5A) . The observed K D of 10.9 nM (Fig. 5A) is compatible with that observed by previous reports in a number of different human and animal cells and cell lines (10, 11, 13, 14, 44) . This site is membrane-bound (Figs. 3-5 ) and shows similarities to membrane testosterone binding site in macrophages and T-lymphocytes (10, 11).
Another possible explanation of the observed membrane binding of testosterone could be its binding to SHBG receptors, via a preliminary binding of testosterone to SHBG, or the presence of intracellular testosterone receptors, tightly bound to plasma membranes. Indeed, intracellular androgen receptors are localized mainly in the cytosol, in contrast to other steroid receptors (29) , and such a binding has been previously reported (48, 49) . Nevertheless, our findings show similar results in both whole cells (Figs. 3 and 4 ) and cell membranes (Fig. 5) by using a nonpermeable testosterone-BSA conjugate. That cells were cultured in the absence of serum rules out SHBG binding. In addition, extensive washing and long incubation times diminish the possibility of an intracellular receptor being bound on cell membranes.
The results of the present study indicate that the activation of membrane testosterone receptors induces the secretion of PSA from LNCaP cells, in a dose-and time-related manner (Fig. 1B) . PSA synthesis and secretion has been described as a genomic testosterone effect, which, as shown in Figure 1A , occurs after relatively long incubation periods (2) . To exclude such a genomic action of testosterone, we have repeated the experiments by using a non-permeable testosterone-BSA conjugate. As shown in Figure 1B , this conjugate has exactly the same effects as on PSA secretion, indicating a membrane effect of testosterone on PSA secretion by LNCaP cells. An alternative explanation of our data could be that the BSA-conjugated testosterone might be contaminated with small quantities of the free hormone, which could produce PSA secretion after intracellular translocation and binding to intracellular androgen receptors. Nevertheless, repeating the experiments with different batches of testosterone-BSA and testosterone-BSA-FITC, we have obtained very similar results and have ruled out this possibility. In addition, the fact that equimolar concentrations of DHT and testosterone-BSA, as well as flutamide, produced similar results provides strong evidence that the same (membrane) testosterone site might be implicated in the observed secretory result.
It is well known that actin cytoskeleton changes play a central role in early cellular responses induced by a variety of stimuli (8, 32, (50) (51) (52) (53) (54) . Several cellular functions, such as endo-and exocytosis, secretion, membrane trafficking, and membrane transport, involve changes in the polymerization state of actin (23, 26, 55, 56) . Our results, presented in Figures 6-8 , show that this is the case in our study. Indeed, PSA secretion under DHT is reversed completely by the blocker of actin polymerization cytochalasin B (Fig. 6) , whereas short-term actions of both testosterone and testosterone-BSA modify profoundly the redistribution of monomeric and polymeric actin (Fig. 7) and remodel completely the actin cytoskeleton (Fig. 8) . It is not clear from our results whether this redistribution is the effect of testosterone on the exocytosis of PSAcontaining vesicles or the preliminary phase of an endocytotic process of the testosteronereceptor complex reported in other systems (10, 11) . However, this explanation cannot be supported by the flow cytometry and microscopic data presented in Figures 3 and 4 . In addition, preliminary results from our laboratory indicate that testosterone membrane signaling triggers actin-regulating proteins, indicating a direct implication of these membrane receptors on cytoskeletal reorganization, which may regulate both trafficking and secretion of molecules, including PSA (Papakonstanti et al, unpublished observations).
In conclusion, the results reported here identify for the first time a membrane functional androgen receptor, which differs from the classical intracellular androgen binding molecules. We have shown that this membrane site is involved in early androgen-related PSA secretion, and in the remodeling of the submembranous actin cytoskeleton structures. It should be of great interest to investigate the possible expression of this site in normal, adenomatous, and neoplastic lesions of the prostate (currently under investigation). Implication of this site to the reorganization of the cellular cytoskeleton and activation of actin signaling molecules could provide useful additional hints for prostate cancer chemotherapy, in which cytoskeleton-modifying agents (27) are used with promising results. 30,000 LNCaP cells, were cultured in 24-well plates for 48 h in the presence of serum and an additional 24 h in a serumfree medium. Thereafter, different concentrations of DHT ranging 10 -12 -10 -6 M for 24 h were added, and incubation was continued for another 24 h. After that, medium was aspirated, centrifuged at 1500 x g, and PSA was assayed. Results were normalized by the number of cells (assayed by the tetrazolium method) and were expressed as a percentage of the untreated cells (control). B) Short-term secretion: Cells were incubated with DHT (10 2 ) flasks. They were then scrapped, centrifuged at 1500 x g, and washed twice with PBS; smears were distributed on SuperFrost/Plus slides. Then they were stained with a primary anti-androgen receptor antibody, as indicated under Materials and Methods. Specific antibody binding was revealed by a second alkaline phosphatase-conjugated antibody. Microscopic image at a 400× magnification. 
